equity injection and cnp strategy

Anyone else hoping that an 'equity injection' is NOT on the cards for CNP (as has been floating around)? - I can't see that any equity injection by an insto atm could be at a decent price. Dilution at these levels would be about the worst thing that could happen to the shareholder wealth.

Expecting Rufrano to do the following in the next 2-3 months:

1. Sell down a few billion of assets in the Australian wholesale fund at slightly above/or at book value.
2. Retain management rights to the wholesale fund at the same time.
3. Reduce gearing levels to more conservative levels and therefore achieve the 'recapitalisation' for which the banks are screaming.
4. Refinance short term debt with longer term debt on favourable terms (possibly in USD) and re-instate hedging.

Next 6-12 months:

1. Reinstate divvy.

Anyone else expecting anything different? And why wouldn't the share price be trading at at least NTA at that time. Bought 50k at 0.50 and if Rufrano performs as expected, not selling out below $4.00. An equity injection though would sucker punch NTA per share...

There's a concept for the down-rampers to look up... NTA (net tangible assets)...